NPPB and coronary artery disorder: Recent research proved that adiponectin (Adpk) is correlated with the presence of atherogenic dyslipidemia and with N-terminal prohormone of brain natriuretic peptide (NT-proBNP) concentration but not with markers of systemic inflammation such as IL-6 or hsCRP in patients with manifested coronary heart diseases [9].